Sunshine Heart can resume trial after FDA OKs 'minor' changes

Sunshine Heart said the FDA will let it resume a clinical trial of its C-Pulse heart failure device after 'minor' protocol changes, following a pause initiated last month after 4 patients died.

Food & Drug Administration (FDA), Sunshine Heart Inc.

News Well, Clinical Trials, Cardiovascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1J7ojnJ